BioCardia, Inc. Files 8-K Report
Ticker: BCDA · Form: 8-K · Filed: Jul 16, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, corporate-reporting
Related Tickers: BCDA
TL;DR
BioCardia filed an 8-K, mostly routine stuff, no major news.
AI Summary
On July 16, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific material events detailed in the provided text. The company, formerly known as Tiger X Medical, Inc., is incorporated in Delaware and headquartered in Sunnyvale, California.
Why It Matters
This 8-K filing indicates routine corporate reporting by BioCardia, Inc., providing updates on financial statements and exhibits without disclosing specific new material events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no indication of significant new risks or material adverse events.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- Tiger X Medical, Inc. (company) — Former company name
- July 16, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Sunnyvale, California (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for BioCardia, Inc.?
The primary purpose of this 8-K filing for BioCardia, Inc. is to report on 'Other Events' and 'Financial Statements and Exhibits'.
When was this 8-K report filed by BioCardia, Inc.?
This 8-K report was filed by BioCardia, Inc. on July 16, 2025.
What was BioCardia, Inc. formerly known as?
BioCardia, Inc. was formerly known as Tiger X Medical, Inc.
In which state is BioCardia, Inc. incorporated?
BioCardia, Inc. is incorporated in Delaware.
What is the address of BioCardia, Inc.'s principal executive offices?
The address of BioCardia, Inc.'s principal executive offices is 320 Soquel Way, Sunnyvale, California 94085.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding BioCardia, Inc. (BCDA).